Soleno Therapeutics, Inc. · NASDAQ:SLNO
Vivo Opportunity Fund Holdings, L.P. reported a 9.70% stake in Soleno Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed Mar 31, 2025
Vivo Opportunity Fund Holdings, L.P. reported a 9.70% stake in Soleno Therapeutics, Inc., 4,458,294 shares, as a passive investor on Mar 31, 2025. Filed Mar 31, 2025 (Schedule 13G/A).
- Stake
- 9.70%
- Shares
- 4,458,294
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. | 9.70% | 4,458,294 |
| Vivo Opportunity, LLC | 9.70% | 4,458,294 |
Source
Related
- Soleno Therapeutics, Inc.
- Vivo Opportunity, LLC
- Soleno Therapeutics, Inc. shareholders
- Schedule 13G/A · Vivo Opportunity, LLC · Nov 14, 2025
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 12, 2025
- Schedule 13G/A · Wellington Management Group LLP · Aug 13, 2026
- Form 4 · Yen Kristen · May 18, 2026
- Form 4 · Volck Birgitte · May 18, 2026
- Form 4 · Sinclair Andrew · May 18, 2026
- Form 4 · Pauls Matthew · May 18, 2026